RecruitingACTRN12621000288820

A randomised controlled trial of ablative fractional CO2 laser and medical needling in children with burn scars


Sponsor

The University of Queensland

Enrollment

70 participants

Start Date

Jun 29, 2021

Study Type

Interventional

Conditions

Summary

Managing scarring remains a significant challenge despite global reductions in burn incidence and severity of burn scars over the last 30 years. Ablative fractional CO2 laser therapy and medical needling are potentially revolutionary and minimally invasive interventions to treat severe burns scars. Laser and needling produce microscopic holes in scar tissue and this process is thought to assist scar tissue remodelling. Needling may have some advantages over laser in terms of feasibility. As there has been minimal investigation of laser and medical needling in children with severe burn scars, there is an urgent need to conduct a rigorous trial within this population. A randomised controlled trial will be conducted at a specialist children’s hospital with a sample of children with severe burn scars. Children will be randomised to one of two intervention groups: ablative fractional CO2 laser therapy or medical needling. The primary outcome of this trial will be ultrasound-assessed scar thickness post-intervention.


Eligibility

Sex: Both males and femalesMax Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

Scarring from burns can cause lasting physical and emotional difficulties, particularly for children. Hypertrophic burn scars are thick, raised, and can restrict movement — affecting everyday activities and self-image. Two minimally invasive treatments have shown promise in improving scar tissue: ablative fractional CO2 laser therapy, which uses a laser to create tiny channels in the scar, and medical needling, which uses fine needles to create a similar effect. Both are thought to trigger the body's natural healing response and help remodel the scar tissue. This study is the first rigorous clinical trial comparing these two treatments directly in children. Participants will be randomly assigned to receive either laser therapy or medical needling. To be eligible, children must be 18 or younger, have hypertrophic (raised, firm) burn scarring at least 6 months after the burn, and be able to attend treatment sessions at the study site. Children who have previously received laser or needling treatment, or who have active skin conditions like eczema, are not eligible. The primary measure of success is the change in scar thickness as measured by ultrasound. The results of this trial will help burn care specialists and families choose the most effective treatment for children living with the long-term effects of burns.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Intervention arm 1 - Ablative fractional CO2 laser therapy + standard care: Ablative fractional CO2 laser therapy will be delivered by a surgeon to each participant under a general anaesthetic using a

Intervention arm 1 - Ablative fractional CO2 laser therapy + standard care: Ablative fractional CO2 laser therapy will be delivered by a surgeon to each participant under a general anaesthetic using a Lumenis Ablative Fractional CO2 laser with SCAAR FX setting; ARTG no. 182239. The dosage applied by the laser intervention will be delivered at one of three depth settings (1-2mm, 60-70mj – shallow skin lesion, 2-3mm, 70-120mj – medium skin lesion, >3mm, 120-150mj – deep skin lesion), which will be determined by ultrasound measurement of scar thickness pre-operatively; and with a standard device setting of 1% density, square size 10, 250Hz, 1 pass with minimal overlapping. The dose applied and areas these doses were applied will be recorded as part of a fidelity checklist. Delivered individually over 1 session at 6 months or more post-burn. Following the intervention any blood and/or exudate will be cleaned, the site will be covered with a Sorbact dressing immediately post-intervention for 24 hours and following that QV intensive moisturising cream will be applied as many times a day as needed to prevent dryness of the skin site. The duration of the intervention will vary for each participant and will be determined by the treating surgeon but will usually be for no longer than 1 hour under general anaesthetic. A hospital-specific factsheet will be provided to the caregivers of participants with post-procedural information (e.g. ongoing treatment, aftercare of the treatment site). Standard care (see below) will continue with the exception of brief cessation of standard care interventions post-operatively. Silicone and pressure garment therapy will be recommenced after re-epithelialisation post laser intervention where appropriate. Intervention arm 2 - Medical needling + standard care: Medical needling will be delivered mechanically by a surgeon to each patient under a general anaesthetic using 3mm needles attached to a roller (Environ Roll-CIT 3mm). The dose applied and areas these doses were applied will be recorded as part of a fidelity checklist. Delivered individually in 1 session at 6-months or more post-burn. Following the intervention any blood and/or exudate will be cleaned, the site will be covered with a Sorbact dressing immediately post-intervention for 24 hours and following that QV intensive moisturising cream will be applied as many times a day as needed to prevent dryness of the skin site. The duration of the intervention will vary for each participant and will be determined by the treating surgeon but will usually be for no longer than 1 hour under general anaesthetic. A hospital-specific factsheet will be provided to the caregivers of participants with post-procedural information (e.g. ongoing treatment, aftercare of the treatment site). Standard care (see below) will continue with the exception of brief cessation of standard care interventions post-operatively. Silicone and pressure garment therapy will be recommenced after re-epithelialisation post needling as appropriate. NB: Standard care may include pressure garments, silicone products, skin or scar massage, exercises, moisturisers, education regarding sun protection. The dose and type of interventions provided is determined by treating health professionals. One or more of these interventions may be provided.


Locations(1)

Queensland Children's Hospital - South Brisbane

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12621000288820


Related Trials